Latest Breaking News On - Sanofi bangladesh - Page 3 : vimarsana.com
Beximco Pharma acquires majority stakes in Sanofi Bangladesh for Tk 400 crore
thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.
Sanofi staff demand benefits before Beximco handover
thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.
Sanofi workers threaten hunger strike Star Business Report Star Business Report
The employees of Sanofi Bangladesh yesterday threatened to go on a hunger strike from Saturday until the company s management fulfills their demands.
The Sanofi Bangladesh Limited Workers-Employees Association (SBLWEA) again alleged that the Sanofi Bangladesh was exiting the country without paying any compensation to its employees.
The SBLWEA made this announcement at a press conference held at the Economic Reporters Forum in Dhaka yesterday.
The briefing came after Beximco Pharmaceuticals recently announced that it was set to acquire a 54.6 per cent stake in Sanofi Bangladesh for about Tk 400 crore as it looks to expand its product base and diversify into new areas.
Beximco Pharmaceuticals Limited ( Beximco Pharma or the Company , or the Group ; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces it has entered into a binding commitment with Sanofi group regarding the acquisition of a majority stake in Sanofi Bangladesh Limited ( Sanofi Bangladesh ) for a base-price consideration of circa £35.5 million, to be adjusted as set out below (the Proposed Transaction ). The Proposed Transaction is subject to approval by the Foreign Exchange Investment Department of Bangladesh Bank and completing the Share Purchase Agreement. · Expands the Company s product offering and reinforces its strategy to diversify into new and expanding specialty therapy areas
vimarsana © 2020. All Rights Reserved.